» Articles » PMID: 3741730

The Psychopharmacological and Electrophysiological Effects of Single Doses of Caffeine in Healthy Human Subjects

Overview
Specialty Pharmacology
Date 1986 Jul 1
PMID 3741730
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of single doses of anhydrous caffeine (250 mg and 500 mg) and placebo on physiological, psychological measures and subjective feelings were studied in a double-blind, cross-over study in nine healthy subjects who had abstained from caffeine-containing beverages for 24 h before each occasion. Caffeine and caffeine metabolites in plasma and urine were assayed. Peak plasma concentrations were observed at 1 to 2 h with an approximate half-life of 5 h. The concentrations of the metabolite 1,7-dimethylxanthine increased during the 5 h. The major urine metabolite was 1-methyluric acid. The EEG showed a dose-related decrease in log 'theta' power and a decrease in log 'alpha' power. Other dose-related effects were an increase in skin conductance level (sweat-gland activity) and self rating of alertness. Ratings of headache and tiredness were decreased by the caffeine. The study illustrates the complexities of studying a drug which is widely taken and which is often associated with withdrawal effects.

Citing Articles

Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.

Grzegorzewski J, Bartsch F, Koller A, Konig M Front Pharmacol. 2022; 12:752826.

PMID: 35280254 PMC: 8914174. DOI: 10.3389/fphar.2021.752826.


Novel insights on caffeine supplementation, CYP1A2 genotype, physiological responses and exercise performance.

Barreto G, Grecco B, Merola P, Reis C, Gualano B, Saunders B Eur J Appl Physiol. 2021; 121(3):749-769.

PMID: 33403509 DOI: 10.1007/s00421-020-04571-7.


Caffeine as a Tool to Explore Active Cognitive Processing Stages in Two-Choice Tasks.

Barry R, Fogarty J, De Blasio F J Caffeine Adenosine Res. 2020; 10(2):71-83.

PMID: 32566904 PMC: 7301320. DOI: 10.1089/caff.2019.0021.


Caffeine enhances sustained attention among adolescents.

Cooper R, Lawson S, Tonkin S, Ziegler A, Temple J, Hawk L Exp Clin Psychopharmacol. 2020; 29(1):82-89.

PMID: 32437192 PMC: 11181358. DOI: 10.1037/pha0000364.


Caffeine Controls Glutamatergic Synaptic Transmission and Pyramidal Neuron Excitability in Human Neocortex.

Kerkhofs A, Xavier A, da Silva B, Canas P, Idema S, Baayen J Front Pharmacol. 2018; 8:899.

PMID: 29354052 PMC: 5758559. DOI: 10.3389/fphar.2017.00899.


References
1.
Dews P . Caffeine. Annu Rev Nutr. 1982; 2:323-41. DOI: 10.1146/annurev.nu.02.070182.001543. View

2.
Levy M . Caffeine metabolism and coffee-attributed sleep disturbances. Clin Pharmacol Ther. 1983; 33(6):770-5. DOI: 10.1038/clpt.1983.105. View

3.
Scott N, Chakraborty J, Marks V . Determination of caffeine, theophylline and theobromine in serum and saliva using high-performance liquid chromatography. Ann Clin Biochem. 1984; 21 ( Pt 2):120-4. DOI: 10.1177/000456328402100208. View

4.
Granit L, Levy M . Relationship between caffeine concentrations in plasma and saliva. Clin Pharmacol Ther. 1984; 36(1):133-7. DOI: 10.1038/clpt.1984.151. View

5.
Wells S . Caffeine: implications of recent research for clinical practice. Am J Orthopsychiatry. 1984; 54(3):375-389. DOI: 10.1111/j.1939-0025.1984.tb01504.x. View